pharmacopeia

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Chelating Activity.

Warnings & precautions

Sourced from openFDA

W ARNING: Chemicals in various preparations can interact with the pessary material resulting in discoloration or deterioration of the pessary. TRIMO-SAN does not have a deleterious effect on any Milex pessary. Testing should be performed before using any other vaginal preparation with a pessary unless specifically prescribed by your healthcare professional.

Use in specific populations

Sourced from openFDA

TRIMO-SAN and PREGNANCY TRIMO-SAN has NOT been tested for use during pregnancy. CooperSurgical does not recommend the use of TRIMO-SAN during pregnancy. If you wish to become pregnant, do not use TRIMO-SAN or any other personal hygiene product vaginally (douches, vaginal sprays, jellies or suppositories), for 6 hours prior to or following intercourse. Any product used within this time period could interfere with conception.

Approval history

Sourced from openFDA
  • Dec 24, 1985NDANDA019044Ge Healthcare
  • Jul 25, 2018ANDAANDA202586Bwxt Itg

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
38 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Death411%
  2. 2Dyspnoea411%
  3. 3Fatigue411%
  4. 4Hot Flush37.9%
  5. 5Off Label Use37.9%
  6. 6Urinary Tract Infection37.9%
  7. 7Abdominal Pain25.3%
  8. 8Acute Kidney Injury25.3%
  9. 9Arthralgia25.3%
  10. 10Chills25.3%
  11. 11Decreased Appetite25.3%
  12. 12Diarrhoea25.3%
  13. 13Drug Ineffective25.3%
  14. 14Heart Rate Increased25.3%
  15. 15Inappropriate Schedule Of Product Administration25.3%

Literature

View JSON

Recent PubMed references pinned to Oxyquinoline as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 10 ClinicalTrials.gov registrations naming Oxyquinoline as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Oxyquinoline work?
Mechanism-of-action class: Chelating Activity.
What class of drug is Oxyquinoline?
Oxyquinoline is classified as Antiinfectives and antiseptics for local oral treatment, Antiseptics, Quinoline derivatives, Chelating Activity, Unknown Physiological Effect.
What are the brand names for Oxyquinoline?
Oxyquinoline is marketed under brand names including Fem pH, Relagard, Trimo San.
Note. Data for oxyquinoline is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients